0001225208-15-019092.txt : 20151002
0001225208-15-019092.hdr.sgml : 20151002
20151002162151
ACCESSION NUMBER: 0001225208-15-019092
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151001
FILED AS OF DATE: 20151002
DATE AS OF CHANGE: 20151002
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
BUSINESS PHONE: 508-683-4000
MAIL ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pratt Timothy A.
CENTRAL INDEX KEY: 0001432178
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 151140600
MAIL ADDRESS:
STREET 1: C/O BOSTON SCIENTIFIC
STREET 2: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
4
1
doc4.xml
X0306
4
2015-10-01
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001432178
Pratt Timothy A.
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH
MA
01752-1234
1
EVP, GC & Chief Admin Officer
Common Stock
2015-10-01
4
M
0
17000.0000
13.5600
A
339893.0000
D
Common Stock
2015-10-01
4
S
0
17000.0000
16.3331
D
322893.0000
D
Stock Option (Right to Buy)
13.5600
2015-10-01
4
M
0
17000.0000
13.5600
D
2018-05-01
Common Stock
17000.0000
188761.0000
D
The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.33 to $16.34, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Grant to the reporting person of an option to purchase 205,761 shares of common stock vesting in four equal annual installments commencing on May 1, 2009, the first anniversary of the date of grant.
/s/ Lee G. Giguere, Attorney-in-Fact
2015-10-02